Diaxxo AG

medical devices

About

Diaxxo AG is a Swiss medtech startup founded in 2020, originating from the Functional Materials Laboratory at ETH Zürich. The company focuses on developing Point-of-Care (PoC) molecular diagnostic solutions, particularly a user-friendly Polymerase Chain Reaction (PCR) device. This innovative machine allows for fast and accurate DNA analysis and disease detection outside traditional laboratory environments. The core product is a pyramid-shaped PoC PCR machine that comes with pre-loaded test cartridges, simplifying the testing process for healthcare professionals. This system enables a sample-to-result workflow without the need for cold chain logistics, making it accessible and easy to use. Diaxxo aims to democratize access to reliable diagnostics, enhancing patient care and public health outcomes. Their technology has been extensively field-tested, including studies for rapid COVID-19 detection, and they are currently pursuing regulatory certification to meet medical device standards. Target customers include doctors' offices, clinics, and healthcare institutions looking for efficient molecular diagnostic tools.

Technologies

Outlook Google Cloud Hosting Mobile Friendly Google Tag Manager Apache WordPress.org reCAPTCHA Google Maps (Non Paid Users) Google Maps Vimeo IoT Blackline Remote

Keywords

ivd molecular diagnostics diagnostics ivd & poc medtech pcr poc medical equipment manufacturing pcr for infectious diseases preloaded cartridges infectious disease diagnostics pcr for schistosomiasis multiplex pathogen detection pcr reagents high accuracy magnetic beads extraction disease detection pcr for helminths dry reagent cartridges laboratory equipment & supplies variant detection pcr for malaria high throughput testing pcr cartridges cost-effective diagnostics pcr for dengue dna/rna extraction pcr for borreliosis pcr for monkeypox covid-19 testing

Location

Vladimir-Prelog-Weg, Zurich, Zurich, Switzerland, 8049

Related Companies

Companies in the same industry